Granting Stock Options to Directors and Employees
First written in FY2019-Q3. 2 of 5 entries say "Achieved", first in FY2024-Q3. Latest entry: FY2024.
- FY2024AchievedAnnual report
「All of the Second Series Stock Acquisition Rights (stock options) lapsed upon expiry of the exercise period on 30 November 2023.」
All of the Second Series Stock Acquisition Rights for directors and employees lapsed upon expiry of the exercise period, and a gain on reversal of stock acquisition rights of ¥48 million was recognized. - FY2024-Q3AchievedAnnual report
「Gain on reversal of stock acquisition rights — 48」
For the previously disclosed stock options granted to directors and employees, the status of stock acquisition rights and other instruments for the third quarter was reported as “No applicable matters,” while a gain on reversal of stock acquisition rights of ¥48 million was recognized in the income statement. - FY2021AdvancedAnnual report
「Stock options not yet vested (shares) End of previous consolidated fiscal year: 57,600 Lapsed: 1,000 Vested: 56,600 Remaining unvested: —」
For the stock options granted to directors and employees, 56,600 shares vested after reflecting the lapsed options, leaving no unvested balance. - FY2020RestatedAnnual report
「Number of stock acquisition rights (units)*: 576; class, description and number of shares underlying the stock acquisition rights (shares): common shares, 57,600; exercise period for stock acquisition rights*: from 1 December 2020 to 30 November 2023」
For the 2018 stock options granted to directors and employees, the company disclosed 576 stock acquisition rights and 57,600 underlying shares after reflecting the rights that had lapsed, together with the exercise period. - FY2019-Q3First statedAnnual report
「Date of resolution 20 June 2018 Categories and number of persons eligible for the grant (people) Directors of the company, excluding directors who are Audit and Supervisory Committee members: 6 Employees of the company: 88 Number of stock acquisition rights (units)* 580 (Note 1) Exercise period for stock acquisition rights* From 1 December 2020 To 30 November 2023」
The company granted 580 stock acquisition rights, representing 58,000 underlying shares, to 6 directors and 88 employees. The exercise period is from 1 December 2020 to 30 November 2023, and the exercise price is ¥3,936 per share.